Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glycemic Control Assessed by Continuous Glucose Monitoring in Hemodialyzed Patients With Diabetes Mellitus Treated Via the Basal-Bolus Detemir-Aspart Insulin Regimen: A Pilot Study

NCT01828970 is registered in ClinicalTrials.gov with Centre Europeen d'Etude du Diabete as lead sponsor.

NCT NCT01828970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01828970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glycemic Control Assessed by Continuous Glucose Monitoring in Hemodialyzed Patients With Diabetes Mellitus Treated Via the Basal-Bolus Detemir-Aspart Insulin Regimen: A Pilot Study
Lead sponsor
Centre Europeen d'Etude du Diabete
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
September 30, 2012
Enrollment
38 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus